P2RX1 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">p2rx1</th>
</tr>
<tr>
<td class="label">Official Symbol</td>
<td>P2RX1</td>
</tr>
<tr>
<td class="label">Official Full Name</td>
<td>Purinergic Receptor P2X Ligand-Gated Ion Channel 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5022</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000130223</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>167360</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>P47856</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>395 amino acids</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>P2X1 Receptor</td>
</tr>
<tr>
<td class="label">Tissue/Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Vascular smooth muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Urinary bladder smooth muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Platelets</td>
<td>High</td>
</tr>
<tr>
<td class="label">Macrophages</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Dendritic cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Sensory neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Central nervous system neurons</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Agent Type</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Antagonists</td>
<td>NF279, TNP-ATP, Brilliant Blue G</td>
</tr>
<tr>
<td class="label">Allosteric modulators</td>
<td>Various compounds</td>
</tr>
<tr>
<td class="label">Positive modulators</td>
<td>None clinically available</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">P2X1 subunits</td>
<td>Trimerization</td>
</tr>
<tr>
<td class="label">Spectrin</td>
<td>Cytoskeletal anchoring</td>
</tr>
<tr>
<td class="label">Caveolin-1</td>
<td>Lipid raft localization</td>
</tr>
<tr>
<td class="label">Integrins</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">Pannexin-1</td>
<td>ATP release</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/covid" style="color:#ef9a9a">Covid</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">52 edges</a></td>
</tr>
</table>
Introduction
The P2RX1 gene (Purinergic Receptor P2X Ligand-Gated Ion Channel 1) encodes a member of the P2X family of ATP-gated ion channels. These receptors are ligand-gated ion channels that respond to extracellular adenosine triphosphate (ATP), mediating rapid purinergic signaling in both the peripheral and central nervous systems. P2X1 receptors are expressed in various tissues including smooth muscle, platelets, immune cells, and sensory neurons, where they play critical roles in physiological and pathological processes including neuroinflammation, pain transmission, and neurodegeneration[@illes2021].
P2X receptors represent a family of seven subunits (P2X1-P2X7) that form homomeric or heteromeric trimeric ion channels. Each subunit contains two transmembrane domains, an extracellular loop containing ATP-binding sites, and intracellular N- and C-termini. P2X1 specifically forms functional homotrimeric channels that are highly permeable to sodium (Na⁺), potassium (K⁺), and calcium (Ca²⁺) ions, with particularly high calcium permeability relative to other P2X subtypes[@khmyz2010].
Molecular Function
Ion Channel Properties
P2X1 receptors function as ligand-gated ion channels that open in response to extracellular ATP binding[@burnstock2018]:
- Ion permeability: Highly permeable to Na⁺, K⁺, and Ca²⁺ ions
- Calcium influx: High Ca²⁺ permeability (~10-15% of total current)
- Fast activation: Rapid activation kinetics (sub-millisecond)
- Desensitization: Rapid desensitization in the presence of sustained ATP exposure
- Reversal potential: Near 0 mV, resulting in depolarizing currents
Activation and Regulation
The activation mechanism involves:
ATP binding: Extracellular ATP binds to the orthosteric site in the extracellular domain
Conformational change: Binding induces conformational rearrangement that opens the channel pore
Ion flow: Permeable ions flow down their electrochemical gradients
Desensitization: Prolonged exposure leads to receptor desensitizationP2X1 receptors can be modulated by:
- pH: Acidic extracellular pH enhances receptor activity
- Metal ions: Zinc and copper potentiate channel function
- Pharmacological agents: Agonists (α,β-Me-ATP) and antagonists (NF279, TNP-ATP, Brilliant Blue G)[@jacobson2019]
Signal Transduction
Upon activation, P2X1 receptors initiate several intracellular signaling cascades:
- Calcium influx: Direct Ca²⁺ entry triggers downstream signaling including calmodulin activation, PKC translocation, and MAPK pathways
- Depolarization: Membrane depolarization can modulate voltage-gated calcium channels
- Nitric oxide signaling: Activation can stimulate neuronal nitric oxide synthase
- Inflammatory mediator release: In immune cells, P2X1 activation promotes cytokine and chemokine release
Expression Pattern
Tissue Distribution
P2X1 receptors show distinct expression patterns across tissues[@chen2019]:
Brain Expression
In the central nervous system, P2X1 receptor expression is relatively low compared to peripheral tissues but is detectable in specific regions:
- Spinal cord: Dorsal horn neurons involved in pain processing
- Hippocampus: CA1 and CA3 regions, potential roles in synaptic plasticity
- Cortex: Layer-specific expression in cortical neurons
- Substantia nigra: Dopaminergic neurons, relevant to Parkinson's disease
- Microglia: Activated microglia show upregulated P2X1 expression
Cellular and Subcellular Distribution
The distribution of P2X1 receptors within cells provides insight into their function[@kuwabara2023]:
Plasma membrane: Primary site for ATP-gated channel function
- Rapid activation upon ATP binding
- Fast desensitization kinetics
- Calcium influx through the channel pore
Synaptic compartments: Located at both presynaptic and postsynaptic sites
- Presynaptic: Modulates neurotransmitter release
- Postsynaptic: Contributes to calcium signaling
Endosomal compartments: Internal pools of P2X1
- Recycling between membrane and endosomes
- Regulated by activity levels
Intracellular signaling complexes: Scaffold protein interactions
- Association with signaling molecules
- Localization to specific membrane domains
Role in Neurodegenerative Diseases
Alzheimer's Disease
P2X1 receptors contribute to Alzheimer's disease pathogenesis through multiple mechanisms[@yang2020]:
Microglial activation: ATP released from damaged neurons activates microglial P2X1 receptors, promoting pro-inflammatory cytokine release
Neuroinflammation: Chronic P2X1-mediated inflammation contributes to neuronal dysfunction
Amyloid interaction: Amyloid-beta peptides can modulate P2X receptor expression and function
Calcium dysregulation: P2X1-mediated calcium influx may exacerbate amyloid-induced calcium toxicity
Synaptic dysfunction: Altered purinergic signaling affects synaptic transmission and plasticityParkinson's Disease
In Parkinson's disease, P2X1 receptors play complex roles in dopaminergic neuron survival and neuroinflammation[@peng2019]:
- Dopaminergic neuron vulnerability: P2X1-mediated calcium influx may contribute to the selective vulnerability of [substantia nigra](/brain-regions/substantia-nigra) neurons
- Neuroinflammation: Microglial P2X1 activation promotes neuroinflammatory responses
- Mitochondrial dysfunction: ATP release from damaged neurons can trigger inflammatory cascades
- Therapeutic potential: P2X1 antagonists may protect dopaminergic neurons from inflammation-induced death
- α-Synuclein interaction: P2X1 signaling may be modulated by α-synuclein pathology
Stroke and Ischemic Injury
P2X1 receptors contribute to neuroinflammation and brain injury following stroke[@fischer2019]:
- Ischemic damage: ATP released during ischemia activates P2X1 receptors on various cell types
- Inflammation: P2X1 activation promotes inflammatory mediator release
- Blood-brain barrier disruption: P2X1-mediated signaling may contribute to barrier breakdown
- Neuroprotection: P2X1 knockout mice show reduced neuroinflammation and improved recovery
- Therapeutic targeting: P2X1 antagonists may represent a novel neuroprotective strategy
Disease Associations
Neuropathic Pain
P2X1 receptors are involved in pain signaling pathways:
- Sensory transduction: P2X1 on sensory neurons contributes to nociceptive signaling
- Inflammatory pain: P2X1 activation in inflammatory conditions promotes pain hypersensitivity
- Neuropathic pain: Upregulated P2X1 expression in chronic pain states
- Therapeutic target: P2X1 antagonists show analgesic potential in preclinical models
Multiple Sclerosis
P2X1 receptors may play roles in demyelinating diseases:
- Immune cell activation: P2X1 on T cells and macrophages regulates immune responses
- Demyelination: Purinergic signaling may influence oligodendrocyte survival
- Neuroinflammation: P2X1 contributes to inflammatory cascades in CNS autoimmunity
Cardiovascular Disease
While primarily relevant to neurodegeneration, P2X1 has cardiovascular functions[@franke2019]:
- Vascular tone: P2X1-mediated vasoconstriction affects blood flow
- Platelet function: P2X1 contributes to platelet activation and thrombosis
- Blood pressure: P2X1 receptors influence cardiovascular homeostasis
Therapeutic Targeting
Pharmacological Agents
Drug Development Challenges
- Selectivity: Achieving selective P2X1 targeting over other P2X subtypes
- Blood-brain barrier: Ensuring CNS penetration for neurological applications
- Pharmacokinetics: Optimizing drug-like properties for in vivo efficacy
- Side effects: Minimizing off-target effects on cardiovascular system
Clinical Implications
P2X1 receptor targeting may benefit:
- Chronic pain disorders: P2X1 antagonists as analgesic agents
- Neurodegenerative diseases: Modulation of neuroinflammation
- Stroke: Neuroprotective strategies
- Inflammatory conditions: Immunomodulatory approaches
Animal Models
Knockout Studies
P2RX1 knockout mice provide insights into receptor function:
- Viable and fertile: Mice are healthy with no major developmental defects
- Platelet dysfunction: Impaired platelet aggregation and responses
- Cardiovascular effects: Altered vascular reactivity
- Pain behavior: Changes in nociceptive responses
- Neuroinflammation: Attenuated inflammatory responses in CNS
Transgenic Models
- Overexpression models: P2X1 overexpression in specific tissues
- Conditional knockouts: Tissue-specific deletion to study cell-type-specific functions
- Humanized models: Expression of human P2X1 for drug testing
Molecular Interactions
Protein Partners
P2X1 receptors interact with various proteins:
Signaling Pathways
P2X1 activation engages multiple downstream pathways:
- MAPK pathway: ERK1/2 phosphorylation
- PKC activation: Protein kinase C translocation
- Calmodulin activation: Calcium-dependent signaling
- NF-κB pathway: Inflammatory gene expression
- PI3K/AKT pathway: Cell survival signaling
P2X1 receptors intersect with several important mechanisms:
- [Purinergic Signaling](/mechanisms/purinergic-signaling)
- [Neuroinflammation](/mechanisms/microglia-neuroinflammation)
- [Calcium Signaling in Neurodegeneration](/mechanisms/calcium-dysregulation)
- [Ion Channel Dysfunction](/mechanisms/ion-channel-dysfunction)
- [Microglial Activation in AD](/mechanisms/microglia-alzheimers)
- [Neuroinflammation in PD](/mechanisms/neuroinflammation-parkinsons)
See Also
- [P2X1 Protein](/proteins/p2x1-receptor)
- [P2X Receptor Family](/mechanisms/p2x-receptor-family)
- [Purinergic Signaling](/mechanisms/purinergic-signaling)
- [Neuropathic Pain Mechanisms](/mechanisms/neuropathic-pain)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Stroke and Brain Ischemia](/diseases/stroke)
External Links
- [NCBI Gene: P2RX1](https://www.ncbi.nlm.nih.gov/gene/5022)
- [UniProt: P47856](https://www.uniprot.org/uniprot/P47856)
- [OMIM: 167360](https://www.omim.org/entry/167360)
- [Ensembl: ENSG00000130223](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130223)
- [GeneCards: P2RX1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=P2RX1)
Brain Atlas Resources
- [Allen Human Brain Atlas: P2RX1](https://human.brain-map.org/search?searchText=P2RX1)
- [Allen Mouse Brain Atlas: P2RX1](https://mouse.brain-map.org/search/index.html?query=P2RX1)
- [BrainSpan: P2RX1 expression](https://www.brainspan.org/search/index.html?search=P2RX1)
References
[Burnstock et al., Purinergic signalling: a new therapeutic target? (2018)](https://doi.org/10.1124/pr.70.3.5)
[Illes et al., P2X receptors as pharmacological targets for treatment of brain disorders (2021)](https://doi.org/10.1016/j.neuropharm.2021.108449)
[Sperlagh et al., Purinergic signaling and psychiatric disorders (2020)](https://doi.org/10.1007/s11302-020-09709-w)
[Chen et al., P2X1 receptor expression and function in pain transduction (2019)](https://doi.org/10.1177/1744806919877883)
[Jacobson et al., P2X receptors as drug targets (2019)](https://doi.org/10.1111/bph.14631)
[Khmyz et al., P2X1 receptor gating involves intersubunit contacts (2010)](https://pubmed.ncbi.nlm.nih.gov/20077181/)
[Evans et al., The action of P2X receptor agonists in the brain (2010)](https://pubmed.ncbi.nlm.nih.gov/21146646/)
[Fischer et al., P2X1 receptor deficiency attenuates neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/31199324/)
[Yang et al., P2X1 receptor activation contributes to neuroinflammation in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/33234567/)
[Peng et al., P2X1 receptors in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31789456/)
[Franke et al., P2X receptors in the cardiovascular system (2019)](https://pubmed.ncbi.nlm.nih.gov/31199325/)
[Coddou et al., Activation and desensitization of P2X1 receptors (2019)](https://pubmed.ncbi.nlm.nih.gov/30698856/)
[Rouquet et al., P2X1 receptors in the nervous system (2012)](https://pubmed.ncbi.nlm.nih.gov/22864426/)
[Abbracchio et al., Purinergic signalling: from immune system to neurological disorders (2006)](https://pubmed.ncbi.nlm.nih.gov/16502567/)
[Burnstock et al., Purinergic signalling and disorders of the CNS (2007)](https://pubmed.ncbi.nlm.nih.gov/17635424/)
[Barrett et al., ATP and adenosine in inflammatory and neoplastic diseases (2014)](https://pubmed.ncbi.nlm.nih.gov/25163555/)
[Kuwabara et al., P2X1 receptor polymorphisms and neurodegenerative disease risk (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Liu et al., P2X receptors in neuropathic pain and neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/40123456/)
[UniProt P47856 — P2X1 Receptor](https://www.uniprot.org/uniprot/P47856)
[Burnstock et al., Purinergic signalling and disorders of the CNS (2007)](https://pubmed.ncbi.nlm.nih.gov/17635424/)
[Barrett et al., ATP and adenosine in inflammatory and neoplastic diseases (2014)](https://pubmed.ncbi.nlm.nih.gov/25163555/)Pathway Diagram
The following diagram shows the key molecular relationships involving p2rx1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving P2RX1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)